Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

DarioHealth stock

DRIO
US23725P2092
A2PU1R

Price

1.13 USD
Today +/-
+0.08 USD
Today %
+8.29 %
P

DarioHealth stock price

USD
%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the DarioHealth stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the DarioHealth stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the DarioHealth stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze DarioHealth's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

DarioHealth Stock Price History

DateDarioHealth Price
10/4/20241.13 USD
10/3/20241.04 USD
10/2/20241.03 USD
10/1/20241.00 USD
9/30/20241.12 USD
9/27/20241.07 USD
9/26/20240.97 USD
9/25/20240.92 USD
9/24/20240.96 USD
9/23/20240.93 USD
9/20/20241.00 USD
9/19/20241.00 USD
9/18/20240.90 USD
9/17/20240.87 USD
9/16/20240.91 USD
9/13/20240.95 USD
9/12/20240.83 USD
9/11/20240.79 USD
9/10/20240.79 USD
9/9/20240.82 USD
9/6/20240.84 USD

DarioHealth Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into DarioHealth, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by DarioHealth from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects DarioHealth’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of DarioHealth. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into DarioHealth’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing DarioHealth’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on DarioHealth’s growth potential.

DarioHealth Revenue, EBIT and net profit per share

DateDarioHealth RevenueDarioHealth EBITDarioHealth Net Income
2028e167.91 M USD0 USD0 USD
2027e87.39 M USD0 USD0 USD
2026e51.27 M USD-60.91 M USD-26.65 M USD
2025e37.74 M USD-49.34 M USD-24.4 M USD
2024e27.76 M USD-60.66 M USD-31.55 M USD
202320.35 M USD-56.19 M USD-63.51 M USD
202227.66 M USD-56.81 M USD-63.84 M USD
202120.51 M USD-76.49 M USD-78.77 M USD
20207.58 M USD-29.9 M USD-33.1 M USD
20197.56 M USD-17.71 M USD-20.89 M USD
20187.39 M USD-17.69 M USD-18.3 M USD
20175.17 M USD-14.42 M USD-16 M USD
20162.8 M USD-10.83 M USD-11.61 M USD
2015820,000 USD-7.7 M USD-7.3 M USD
201450,000 USD-10.87 M USD-16.06 M USD
20130 USD-13.56 M USD-13.93 M USD
20120 USD-3.97 M USD-5.69 M USD
20110 USD-230,000 USD-390,000 USD

DarioHealth Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M USD)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M USD)EBIT (M USD)EBIT MARGIN (%)NET INCOME (M USD)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e
000002577720272027375187167
------150.0040.00--185.7135.00-25.9335.0037.0437.8470.5991.95
------20.0014.2928.5728.5715.0033.3325.00-----
000-200112239500000
0-3-13-10-7-10-14-17-17-29-76-56-56-60-49-6000
------500.00-280.00-242.86-242.86-414.29-380.00-207.41-280.00-222.22-132.43-117.65--
0-5-13-16-7-11-16-18-20-33-78-63-63-31-24-2600
--160.0023.08-56.2557.1445.4512.5011.1165.00136.36-19.23--50.79-22.588.33--
0.010.010.010.020.090.260.481.172.275.9616.5923.6428.3700000
------------------
Details

Keystats

ⓘ

Revenue and Growth

The DarioHealth Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the DarioHealth is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M USD)RECEIVABLES (M USD)OTHER REC. (M USD)INVENTORIES (M USD)OTHER CURRENT LIAB. (M USD)CURRENT ASSETS (M USD)TANGIBLE ASSETS (M USD)LONG-T. INVEST. (M USD)LONG-T. REC. (M USD)INTANGIBLE ASSETS (M USD)GOODWILL (M USD)OTHER NON-CURRENT ASSETS (k USD)NON-CURRENT ASSETS (M USD)TOTAL ASSETS (M USD)LIABILITIESCOMMON STOCK (k USD)ADDITIONAL PAID-IN CAPITAL (M USD)RETAINED EARNINGS (M USD)OTHER EQUITY (M USD)UNREAL. GAINS/LOSSES (M USD)EQUITY (M USD)LIABILITIES (M USD)PROVISIONS (M USD)OTHER SHORT-TERM LIAB. (M USD)SHORT-TERM DEBTS (M USD)LONG-TERM DEBT PORTION (M USD)SHORT-TERM REC. (M USD)LONG-T. LIAB. (M USD)DEFERRED TAXES (M USD)OTHER LIAB. (M USD)LONG-T. LIABILITIES (M USD)DEBT (M USD)TOTAL CAPITAL (M USD)
2011201220132014201520162017201820192020202120222023
                         
0.91.32.41.52.81.3411.220.628.83649.537.09
000000.20.30.20.70.11.36.43.16
0000000.60.601.50.40.52.02
0000.20.60.91.21.41.42.36.285.06
00.40.50.30.90.5000.31.51.71.10
0.91.72.924.32.96.113.42334.245.665.547.33
00.61.110.70.90.90.71.41.1121.87
0000000000000
0000000000000
000000000012.59.95.4
000000000041.641.641.64
00000000200200100100149
00.61.110.70.90.90.71.61.355.253.649.06
0.92.34353.8714.124.635.5100.8119.196.39
                         
0000000000003
0.6519.930.841.848.474.998.2129171.4307.6365.8407.5
-0.4-6.1-20-36.1-43.4-55-71-89.3-110.1-143.2-222-285.9-349.36
0000000000000
0000000000000
0.2-1.1-0.1-5.3-1.6-6.63.98.918.928.285.679.958.14
00.30.60.711.81.92.61.72.55.12.31.13
0.10.30.90.90.71.1002.33.38.16.96.41
0000001.22.61.21.21.21.31
0000000000000
000000000008.83.95
0.10.61.51.61.72.93.15.25.2714.419.312.49
0002.82.400000018.124.59
0000000000000
0.72.82.742.67.5000.50.20.81.71.16
0.72.82.76.857.5000.50.20.819.825.75
0.83.44.28.46.710.43.15.25.77.215.239.138.25
12.34.13.15.13.8714.124.635.4100.811996.39
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of DarioHealth provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand DarioHealth's financial health and stability.

Assets

DarioHealth's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that DarioHealth must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of DarioHealth after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into DarioHealth's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M USD)DEPRECIATION (M USD)DEFERRED TAXES (M USD)CHANGES IN WORKING CAPITAL (M USD)NON-CASH ITEM (M USD)PAID INTEREST (M USD)PAID TAXES (M USD)NET CASH FLOW FROM OPERATING ACTIVITIES (M USD)CAPITAL EXPENDITURES (M USD)CASH FLOW FROM INVESTING ACTIVITIES (M USD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M USD)INTEREST INCOME AND EXPENSES (M USD)NET DEBT CHANGE (M USD)NET CHANGE IN EQUITY (M USD)CASH FLOW FROM FINANCING ACTIVITIES (M USD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (USD)TOTAL DIVIDENDS PAID (M USD)NET CHANGE IN CASH FLOW (M USD)FREE CASH FLOW (M USD)SHARE-BASED COMPENSATION (M USD)
2011201220132014201520162017201820192020202120222023
0-5-13-12-7-10-15-17-17-29-76-62-59
0000000000344
0000000000000
0111-101200-3-103
02843277422513720
0000000000014
0000000000000
0-2-7-8-6-8-10-11-15-17-50-47-30
00-10000000000
00-1000000-1-800
000000000-1-700
0000000000000
00000000000231
131087713182527653816
131087713182527656118
-------------
0000000000000
00101-12798713-12
-0.16-3.51-9-9.14-6.39-9.19-10.82-11.54-15.83-17.86-50.67-48.42-30.96
0000000000000

DarioHealth stock margins

The DarioHealth margin analysis displays the gross margin, EBIT margin, as well as the profit margin of DarioHealth. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for DarioHealth.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the DarioHealth's sales revenue. A higher gross margin percentage indicates that the DarioHealth retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the DarioHealth's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the DarioHealth's total revenue generated. When comparing the revenue margin year over year, investors can gauge the DarioHealth's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the DarioHealth. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the DarioHealth's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

DarioHealth Margin History

DarioHealth Gross marginDarioHealth Profit marginDarioHealth EBIT marginDarioHealth Profit margin
2028e29.4 %0 %0 %
2027e29.4 %0 %0 %
2026e29.4 %-118.82 %-51.98 %
2025e29.4 %-130.75 %-64.67 %
2024e29.4 %-218.49 %-113.65 %
202329.4 %-276.09 %-312.06 %
202234.92 %-205.39 %-230.8 %
202119.31 %-372.94 %-384.06 %
202033.11 %-394.46 %-436.68 %
201934.39 %-234.26 %-276.32 %
201823.95 %-239.38 %-247.63 %
201725.34 %-278.92 %-309.48 %
2016-20 %-386.79 %-414.64 %
2015-104.88 %-939.02 %-890.24 %
2014-4,440 %-21,740 %-32,120 %
201329.4 %0 %0 %
201229.4 %0 %0 %
201129.4 %0 %0 %

DarioHealth Stock Sales Revenue, EBIT, Earnings per Share

The DarioHealth earnings per share therefore indicates how much revenue DarioHealth has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue DarioHealth earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates DarioHealth's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of DarioHealth’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating DarioHealth's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

DarioHealth Revenue, EBIT and net profit per share

DateDarioHealth Sales per ShareDarioHealth EBIT per shareDarioHealth Earnings per Share
2028e5.59 USD0 USD0 USD
2027e2.91 USD0 USD0 USD
2026e1.71 USD0 USD-0.89 USD
2025e1.26 USD0 USD-0.81 USD
2024e0.92 USD0 USD-1.05 USD
20230.72 USD-1.98 USD-2.24 USD
20221.17 USD-2.4 USD-2.7 USD
20211.24 USD-4.61 USD-4.75 USD
20201.27 USD-5.02 USD-5.55 USD
20193.33 USD-7.8 USD-9.2 USD
20186.32 USD-15.12 USD-15.64 USD
201710.77 USD-30.04 USD-33.33 USD
201610.77 USD-41.65 USD-44.65 USD
20159.11 USD-85.56 USD-81.11 USD
20142.5 USD-543.5 USD-803 USD
20130 USD-1,356 USD-1,393 USD
20120 USD-397 USD-569 USD
20110 USD-23 USD-39 USD

DarioHealth business model

DarioHealth Corp specializes in digital health solutions. It was founded in 2011 and is based in New York, USA. It was founded by Dror Bacher and Oren Fuerst with the goal of helping people with diabetes live healthier lives. They developed a mobile app that allows people with diabetes to monitor their blood sugar levels and improve their health. The company's business model focuses on developing and selling digital health solutions for people with diabetes and other chronic conditions. They work with insurance companies and healthcare providers to sell their products and services to patients. The company is divided into different divisions that cater to the needs of diabetes patients and people with chronic conditions. These divisions include the DarioHealth app, DarioEngage, DarioHealth for Employers, and DarioHealth for Pharma. The company offers a range of products including the DarioHealth Smart Meter, DarioHealth Smart Insulin Pen, and DarioHealth Smart CGM. Overall, DarioHealth Corp is an innovative company that offers tailored digital health solutions for people with diabetes and other chronic conditions. DarioHealth is one of the most popular companies on Eulerpool.com.

DarioHealth SWOT Analysis

Strengths

DarioHealth Corp is a leading provider of digital health solutions, offering a range of innovative products for managing chronic conditions.

The company's flagship product, the Dario Blood Glucose Monitoring System, stands out for its user-friendly design and advanced capabilities in tracking blood sugar levels.

DarioHealth Corp has established strategic partnerships with healthcare providers and insurance companies, which enhances its market reach and provides opportunities for collaboration.

Weaknesses

One of the challenges facing DarioHealth Corp is its relatively small market share compared to larger competitors in the digital health industry.

The company's heavy reliance on technology for its products may pose a barrier for older individuals or those with limited technological literacy.

There is potential for increased competition and market saturation in the digital health space, which can make it challenging for DarioHealth Corp to maintain its competitive edge.

Opportunities

The growing global prevalence of chronic diseases, such as diabetes, presents a significant opportunity for DarioHealth Corp to expand its customer base and market presence.

The increasing adoption of telehealth and remote patient monitoring solutions due to the COVID-19 pandemic creates a favorable environment for DarioHealth Corp to offer its digital health products and services.

There is a rising demand for personalized healthcare solutions, and DarioHealth Corp can capitalize on this trend by further enhancing its data analysis capabilities and customization options.

Threats

DarioHealth Corp faces the risk of potential regulatory changes or compliance issues, particularly regarding data privacy and security.

Intense competition from both established players and emerging startups in the digital health market poses a threat to DarioHealth Corp's market position and revenue growth.

Economic downturns or disruptions in the healthcare industry could adversely affect customer spending on digital health solutions, impacting DarioHealth Corp's financial performance.

DarioHealth Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

DarioHealth historical P/E ratio, EBIT multiple, and P/S ratio

DarioHealth shares outstanding

The number of shares was DarioHealth in 2023 — This indicates how many shares 28.372 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue DarioHealth earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates DarioHealth's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of DarioHealth’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating DarioHealth's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

DarioHealth stock splits

In DarioHealth's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for DarioHealth.

DarioHealth latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.57 USD-0.08 USD (85.87 %)2024 Q2
3/31/2024-0.41 USD-0.2 USD (51.59 %)2024 Q1
12/31/2023-0.56 USD-0.5 USD (11.41 %)2023 Q4
9/30/2023-0.47 USD-0.49 USD (-4.43 %)2023 Q3
6/30/2023-0.53 USD-0.58 USD (-8.94 %)2023 Q2
3/31/2023-0.51 USD-0.45 USD (11.42 %)2023 Q1
12/31/2022-0.67 USD-0.51 USD (23.31 %)2022 Q4
9/30/2022-0.78 USD-0.64 USD (17.75 %)2022 Q3
6/30/2022-0.73 USD-0.74 USD (-1.82 %)2022 Q2
3/31/2022-0.98 USD-0.74 USD (24.2 %)2022 Q1
1
2
3
4

Eulerpool ESG Scorecard© for the DarioHealth stock

Eulerpool World ESG Rating (EESG©)

39/ 100

🌱 Environment

44

👫 Social

30

🏛️ Governance

43

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept❌
Privacy concept—
Occupational health and safety❌
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

DarioHealth shareholders

%
Name
Stocks
Change
Date
7.78140 % Nantahala Capital Management, LLC2,336,753-77,43912/31/2023
4.92623 % Raphael (Erez)1,479,348539,2173/22/2024
4.40374 % Appian Way Asset Management LP1,322,44432,44812/31/2023
4.29077 % More Investment House Ltd.1,288,518012/31/2023
3.93211 % Phoenix Investment and Finances Ltd1,180,813-160,21412/31/2023
3.50657 % Kershner Trading Americas, L.L.C.1,053,024-180,5009/8/2023
2.91696 % Clal Insurance Enterprises Holdings Ltd.875,964-60,70112/31/2023
1.80205 % Ben-David (Zvi)541,155250,1023/22/2024
1.29176 % Stern (Adam K.)387,917191,9493/22/2024
1.20893 % The Vanguard Group, Inc.363,04261,03412/31/2023
1
2
3
4
5
...
10

DarioHealth Executives and Management Board

Mr. Erez Raphael50
DarioHealth Chief Executive Officer, Director (since 2013)
Compensation 2.96 M USD
Mr. Richard Anderson54
DarioHealth President
Compensation 1.73 M USD
Mr. Zvi Ben-David62
DarioHealth Chief Financial Officer, Treasurer, Secretary
Compensation 1.11 M USD
Ms. Hila Karah54
DarioHealth Independent Director
Compensation 645,200 USD
Mr. Yoav Shaked52
DarioHealth Independent Chairman of the Board
Compensation 501,400 USD
1
2

DarioHealth Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Humana Stock
Humana
SupplierCustomer0,320,16-0,080,050,18-0,14
Best Buy Stock
Best Buy
SupplierCustomer-0,29-0,720,270,560,750,64
1

Most common questions regarding DarioHealth

What values and corporate philosophy does DarioHealth represent?

DarioHealth Corp represents a commitment to empowering individuals and improving their healthcare experience. The company embraces a patient-centric approach, offering innovative digital health solutions that integrate medical devices, software platforms, and data analytics. DarioHealth's corporate philosophy revolves around delivering personalized, real-time insights to help individuals manage and take control of their chronic conditions such as diabetes, hypertension, and obesity. With a focus on accessibility, convenience, and simplicity, DarioHealth aims to enhance the quality of life for those living with chronic conditions through continuous remote monitoring and personalized support.

In which countries and regions is DarioHealth primarily present?

DarioHealth Corp is primarily present in the United States, Canada, and Europe.

What significant milestones has the company DarioHealth achieved?

DarioHealth Corp has achieved several significant milestones. One notable achievement is their FDA clearance for Dario™ Blood Glucose Monitoring System, a mobile-based diabetes management solution. The company has also successfully expanded its global reach by launching in new markets across Europe, Australia, and Canada. DarioHealth Corp's collaboration with major health organizations and telehealth services has further strengthened its position in the digital health market. Moreover, the company consistently strives for innovation, constantly upgrading their technology and adding new features to their platform. DarioHealth Corp's commitment to improving the lives of individuals with chronic conditions makes it a compelling choice for investors seeking growth opportunities in the healthcare industry. (Word count: 108)

What is the history and background of the company DarioHealth?

DarioHealth Corp is a leading digital health company, specializing in mobile health and remote patient monitoring. Founded in 2011, the company has gained recognition for its innovative platform that empowers individuals to manage their chronic conditions effectively. DarioHealth Corp's flagship product, the Dario Blood Glucose Monitoring System, revolutionizes diabetes management by providing real-time feedback and actionable insights. With a strong focus on user experience and data-driven solutions, the company has positioned itself as a pioneer in the digital health industry. DarioHealth Corp's commitment to improving healthcare outcomes has propelled its growth and global presence, making it a trusted and reliable partner for patients, physicians, and healthcare organizations.

Who are the main competitors of DarioHealth in the market?

The main competitors of DarioHealth Corp in the market include Livongo Health Inc., WellDoc Inc., and Glooko Inc. These companies also operate in the digital health and chronic disease management sector, offering similar products and services to DarioHealth Corp. Livongo Health Inc. provides a comprehensive platform for remote monitoring and personalized health insights. WellDoc Inc. offers a digital therapeutic solution for diabetes management. Glooko Inc. specializes in diabetes management and provides a platform for remote patient monitoring. These competitors pose a challenge to DarioHealth Corp in terms of market share and innovation in the digital health space.

In which industries is DarioHealth primarily active?

DarioHealth Corp is primarily active in the healthcare technology sector. With its innovative solutions and advanced digital health platform, the company focuses on offering personalized and integrated remote patient monitoring services. DarioHealth Corp aims to revolutionize the management of chronic conditions by providing real-time data, actionable insights, and improved patient engagement. With its expertise in diabetes management, the company offers a comprehensive suite of digital health solutions that empower individuals to take control of their health. Through its cutting-edge technology and commitment to advancing healthcare, DarioHealth Corp continues to make significant strides in the healthcare industry.

What is the business model of DarioHealth?

DarioHealth Corp is a digital health company that specializes in chronic disease management. Its business model revolves around providing individuals with innovative and user-friendly mobile health solutions. DarioHealth offers a personalized platform that combines digital tools, artificial intelligence, and real-time data analysis to help users monitor, manage, and improve their health conditions. By delivering comprehensive data insights and actionable feedback, DarioHealth empowers individuals to make informed decisions about their well-being. Through strategic partnerships and constant technological advancements, DarioHealth aims to enhance disease management, optimize treatment outcomes, and ultimately improve the quality of life for individuals worldwide.

What is the P/E ratio of DarioHealth 2024?

The DarioHealth P/E ratio is -1.02.

What is the P/S ratio of DarioHealth 2024?

The DarioHealth P/S ratio is 1.15.

What is the AlleAktien quality score of DarioHealth?

The AlleAktien quality score for DarioHealth is 6/10.

What is the revenue of DarioHealth 2024?

The expected DarioHealth revenue is 27.76 M USD.

How high is the profit of DarioHealth 2024?

The expected DarioHealth profit is -31.55 M USD.

What is the business model of DarioHealth

DarioHealth Corp is a company specializing in the production and sale of personalized, mobile health solutions. It utilizes cutting-edge technologies such as artificial intelligence, data analysis, and machine learning to develop individualized health solutions for its customers. The company operates in four main areas, namely diabetes management, hypertension management, weight management, and digital therapeutics. In the diabetes management field, DarioHealth offers an app that allows diabetics to easily and conveniently monitor and manage their blood glucose levels. The app works with a Bluetooth-enabled blood glucose meter and an electronic diary. Through the app, users can also manage their insulin doses and set reminders for doctor visits or medication intake. In the hypertension management area, DarioHealth has developed an innovative solution that enables people with high blood pressure to measure their blood pressure without expensive and complicated devices. The solution consists of an easy-to-use blood pressure monitor connected to an app that displays users' real-time blood pressure readings. The app also alerts the user when their blood pressure is too high and provides tips for lowering blood pressure, such as physical activity or dietary changes. In the weight management segment, DarioHealth offers an app that allows users to track their diet and physical activity. The app uses machine learning to provide personal recommendations and help users achieve their weight loss or weight control goals. Lastly, DarioHealth also has a segment for digital therapeutics, which enables users to access specially designed digital programs for the treatment of conditions such as chronic pain, sleep disorders, or stress. Although DarioHealth's various segments offer different solutions, they all have something in common: they are tailored to the needs and desires of consumers and utilize modern technologies to offer personalized health solutions. The company adopts an innovative approach to change the way people manage and treat their health, providing solutions that are simple, convenient, and effective. DarioHealth earns its revenue by selling its products and services to consumers interested in personalized health solutions. The company also collaborates with insurance companies and healthcare providers to offer its solutions to a larger customer base and reduce healthcare costs. Overall, DarioHealth is a leading company in the field of personalized, mobile health solutions, offering innovative solutions to take consumers' health to a new level.

What is the DarioHealth dividend?

DarioHealth pays a dividend of 0 USD distributed over payouts per year.

How often does DarioHealth pay dividends?

The dividend cannot currently be calculated for DarioHealth or the company does not pay out a dividend.

What is the DarioHealth ISIN?

The ISIN of DarioHealth is US23725P2092.

What is the DarioHealth WKN?

The WKN of DarioHealth is A2PU1R.

What is the DarioHealth ticker?

The ticker of DarioHealth is DRIO.

How much dividend does DarioHealth pay?

Over the past 12 months, DarioHealth paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, DarioHealth is expected to pay a dividend of 0 USD.

What is the dividend yield of DarioHealth?

The current dividend yield of DarioHealth is .

When does DarioHealth pay dividends?

DarioHealth pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of DarioHealth?

DarioHealth paid dividends every year for the past 0 years.

What is the dividend of DarioHealth?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is DarioHealth located?

DarioHealth is assigned to the 'Health' sector.

Wann musste ich die Aktien von DarioHealth kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of DarioHealth from 10/5/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/5/2024.

When did DarioHealth pay the last dividend?

The last dividend was paid out on 10/5/2024.

What was the dividend of DarioHealth in the year 2023?

In the year 2023, DarioHealth distributed 0 USD as dividends.

In which currency does DarioHealth pay out the dividend?

The dividends of DarioHealth are distributed in USD.

All fundamentals about DarioHealth

Our stock analysis for DarioHealth Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DarioHealth Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.